Health systems have worked diligently to ensure that they are in compliance with the revised USP Chapter <797> requirements. This educational activity will demonstrate how health systems of any size can perform a gap analysis of its facility, personnel, policy and procedure development and review, environmental monitoring, and accreditation. Recognizing the important safety features of technologies and standardization of IV compounding, the education will also address how they might be implemented in small, medium, and large institutions.
  RPh, MPA, BCSCP, FASHP Activity Chair   Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania PharmD, MS, BCSCP, FASHP     Director of Inpatient Pharmacy Operations
Nationwide Children's Hospital
Columbus, Ohio PharmD, MS, BCSCP   Director, 503B Program
Premier Inc.
Charlotte, North Carolina   This activity was planned to meet the educational needs of pharmacists, pharmacy technicians, and medication safety officers practicing in hospitals and health systems.   Welcome and Introductions
Patricia C. Kienle   Performing a Gap Analysis: Following the Vials Beyond the Pharmacy  Ashley M. Duty   Maximizing Technology and Standardization to Improve Safety of IV Compounding  Kevin N. Hansen   Faculty Discussion, Questions and Answers All Faculty   ACPE #: 0204-0000-24-403-H07-P, 0204-0000-24-403-H07-T CE Credit: 1.0 contact hour (0.10 CEU) Activity Type: Application-based Activity Fee: No charge Available: May 21, 2024 - May 21, 2025 
To receive CE credit, complete the steps below within 60 days of completing the activity. After the 60-day deadline, ASHP will no longer be able to report credits(s).
 

  Provided by NCCN in partnership with The France Foundation.   Accreditation:
This program has been approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, PAs, and other health care professionals. Fee Information:
There is no fee for this educational program for registrants. Faculty Contributors:   Supporters:
This activity is supported by an educational grant from Genentech, a member of the Roche Group. This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

六月開課 火熱招生中!  6/6 報名截止，請盡快完成報名 
  1. 危害性藥品名單的最大宗為抗癌藥品，不論台灣或東南亞，許多藥師對於危害性藥品的認知、防護觀念、操作防護重點、清潔或被服人員教育、廢棄物的處理，都有待加強。藥師在醫療機構中是所有醫療人員中最適當推動危害性藥品安全防護觀念者。因此，由藥師的教育開始，可以廣泛影響醫療院所中其他職類對於此類藥品防護的注意。 2. 本課程藉由對危害性藥品防護處理的探討，延伸至政府於危害性藥品的管理政策以及廢棄藥品規範等環境議題。 3. 本課程是全國第一個針對危害性藥品完整概念與操作的認證課程，旨在建立危害性藥品處理訓練的標竿，之後也將定期辦理再認證課程。經過合格訓練的學員將了解危害性藥品的風險，學習如何使用個人防護裝備、硬體建築的設置標準與維護，進而保護所有醫療人員及非醫療人員。